Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Aurelius Health Group vs Risen Labs

Aurelius Health Group
Graded #275

Higher grade

vs+5.099999999999994
Risen Labs
Graded #403

Lower grade

The verdict

Aurelius Health Group takes it — 62.3/100 to 57.2/100.

Aurelius Health Group grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Aurelius Health Group is a telehealth platform built around compounded tirzepatide microdosing — a low-dose dual GIP/GLP-1 protocol rather than standard full-dose therapy — with optional NAD+, L-carnitine,…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAurelius Health Group +15
60
45
Dose & formulationAurelius Health Group +12
52
40
Clinical oversightRisen Labs +3
76
79
Labs & monitoringRisen Labs +1
63
64
FulfillmentRisen Labs +7
61
68
Contract termsAurelius Health Group +6
61
55
Aurelius Health Group · left barRisen Labs · right bar

The numbers

MetricAurelius Health GroupRisen Labs
WeighScore62.3/10057.2/100
GradeCC
Scorecard rank#275#403
SemaglutideNot disclosedNot disclosed
Tirzepatide$199/mo (microdose tier, compounded)Not disclosed
CoverageCoverage not published2 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Aurelius Health Group

Graded #275 · C

Strengths

  • Pricing fully published and bundled: $89 first month, then $199/mo all-in — more transparent than most compounded brands
  • LegitScript Certified
  • Care-inclusive model: consults, monthly monitoring, and secure messaging rather than Rx-only
  • Unusually candid about the limited evidence base for microdosing

Where it loses points

  • Microdose-only model — sub-therapeutic doses have thinner trial evidence and likely smaller weight loss than full-dose tirzepatide
  • No semaglutide or standard full-dose option
  • No named compounding pharmacy partner
  • No state list and no named medical director or pharmacist-in-charge
Risen Labs

Graded #403 · C

Strengths

  • Names its compounding pharmacy (Olympia Pharmacy, a 503A compounding pharmacy) and legal entity (Risen Labs LLC)
  • Offers compounded semaglutide and tirzepatide as clinician-guided once-weekly injections
  • Focused clinical intake covering weight loss, men's health, and hormone protocols

Where it loses points

  • GLP-1 pricing is not published; it appears only after you complete the clinical intake
  • Available only to patients in New York and Colorado
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
  • No LegitScript certification is displayed on the site

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard